FUNCTIONAL PERFORMANCE IN THE MODIFIED SHUTTLE TEST IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS

Overview

Journal Rev Paul Pediatr

Specialty Pediatrics

Date 2020 Aug 14

PMID 32785464

Citations 1

Authors

Luanna Rodrigues Leite

Karen Caroline Vasconcelos Queiroz

Cristiane Cenachi Coelho

Alberto Andrade Vergara

Marcio Vinicius Fagundes Donadio

Evanirso da Silva Aquino

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate factors associated with the performance of children and adolescents with cystic fibrosis (CF) in the Modified Shuttle Test (MST) and compare it with healthy children and adolescents.

Methods: This is a cross-sectional study, with children and adolescents divided into two groups: cystic fibrosis (CFG) and control (CG). Variables evaluated in the MST: walking distance, test level, heart rate variation (∆Hr), post-test mean arterial pressure (MAP Pt) and peripheral oxygen saturation variation (∆SPO2). Statistical analysis included Mann Whitney and Spearman coefficient tests, being significant p<0.05.

Results: Sixty individuals aged 6-16 years old were evaluated. Anthropometric data was similar between groups. Differences between groups were shown for: baseline heart rate (BHr), peak heart rate (PHr), ∆Hr, recovery heart rate (RHr), post-test respiratory rate (PtBr), saturation variables, peripheral oxygen level (SpO2B) and level test. The ∆Hr and MAP Pt had a moderate positive correlation with distance and level test for both groups (respectively: r=0.6 / p<0.001; r=0.6 / p<0.001). In CFG, the level test had a significant association (r=0.4 - p=0.02) with %FEV1.

Conclusions: Children with cystic fibrosis presented functional limitation in the Modified Shuttle Test, which was influenced by lung function.

Citing Articles

Guidance and standard operating procedures for functional exercise testing in cystic fibrosis.

Saynor Z, Gruet M, McNarry M, Button B, Morrison L, Wagner M Eur Respir Rev. 2023; 32(169).

PMID: 37558263 PMC: 10410399. DOI: 10.1183/16000617.0029-2023.

References

Holland A, Spruit M, Troosters T, Puhan M, Pepin V, Saey D . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014; 44(6):1428-46. DOI: 10.1183/09031936.00150314. View

Saglam M, Vardar-Yagli N, Savci S, Inal-Ince D, Aribas Z, Bosnak-Guclu M . Six minute walk test versus incremental shuttle walk test in cystic fibrosis. Pediatr Int. 2016; 58(9):887-93. DOI: 10.1111/ped.12919. View

Sabharwal S . Gastrointestinal Manifestations of Cystic Fibrosis. Gastroenterol Hepatol (N Y). 2016; 12(1):43-7. PMC: 4865785. View

Shetler K, Marcus R, Froelicher V, Vora S, Kalisetti D, Prakash M . Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol. 2001; 38(7):1980-7. DOI: 10.1016/s0735-1097(01)01652-7. View

Almajed A, Lands L . The evolution of exercise capacity and its limiting factors in cystic fibrosis. Paediatr Respir Rev. 2012; 13(4):195-9. DOI: 10.1016/j.prrv.2012.01.001. View

Klijn P, van der Net J, Kimpen J, Helders P, van der Ent C . Longitudinal determinants of peak aerobic performance in children with cystic fibrosis. Chest. 2003; 124(6):2215-9. DOI: 10.1378/chest.124.6.2215. View

Borg G . Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14(5):377-81. View

Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A . Standardisation of spirometry. Eur Respir J. 2005; 26(2):319-38. DOI: 10.1183/09031936.05.00034805. View

Florencio R, Fregonezi G, Brilhante S, Borghi-Silva A, Dias F, Resqueti V . Heart rate variability at rest and after the 6-minute walk test (6MWT) in children with cystic fibrosis. Braz J Phys Ther. 2013; 17(5):419-26. View

10.

Singh S, Puhan M, Andrianopoulos V, Hernandes N, Mitchell K, Hill C . An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014; 44(6):1447-78. DOI: 10.1183/09031936.00150414. View

11.

Smith L, Reilly C, MacBean V, Jolley C, Elston C, Moxham J . Physiological markers of exercise capacity and lung disease severity in cystic fibrosis. Respirology. 2016; 22(4):714-720. DOI: 10.1111/resp.12954. View

12.

Isa H, Al-Ali L, Mohamed A . Growth assessment and risk factors of malnutrition in children with cystic fibrosis. Saudi Med J. 2016; 37(3):293-8. PMC: 4800894. DOI: 10.15537/smj.2016.3.13476. View

13.

Bradley J, Kent L, ONeill B, Nevill A, Boyle L, Elborn J . Cardiorespiratory measurements during field tests in CF: use of an ambulatory monitoring system. Pediatr Pulmonol. 2010; 46(3):253-60. DOI: 10.1002/ppul.21360. View

14.

Coelho C, da Silva Aquino E, de Almeida D, Oliveira G, Pinto R, Rezende I . Comparative analysis and reproducibility of the modified shuttle walk test in normal children and in children with cystic fibrosis. J Bras Pneumol. 2007; 33(2):168-74. DOI: 10.1590/s1806-37132007000200011. View

15.

Lanza F, Zagatto E, Silva J, Selman J, Imperatori T, Zanatta D . Reference Equation for the Incremental Shuttle Walk Test in Children and Adolescents. J Pediatr. 2015; 167(5):1057-61. DOI: 10.1016/j.jpeds.2015.07.068. View

16.

Doeleman W, Takken T, Bronsveld I, Hulzebos E . Relationship between lung function and Modified Shuttle Test performance in adult patients with cystic fibrosis: a cross-sectional, retrospective study. Physiotherapy. 2016; 102(2):184-8. DOI: 10.1016/j.physio.2015.10.015. View

17.

Vallier J, Rouissi M, Mely L, Gruet M . Physiological Responses of the Modified Shuttle Test in Adults With Cystic Fibrosis. J Cardiopulm Rehabil Prev. 2016; 36(4):288-92. DOI: 10.1097/HCR.0000000000000181. View

18.

Singh S, Morgan M, Scott S, Walters D, Hardman A . Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992; 47(12):1019-24. PMC: 1021093. DOI: 10.1136/thx.47.12.1019. View

19.

Probst V, Hernandes N, Teixeira D, Felcar J, Mesquita R, Goncalves C . Reference values for the incremental shuttle walking test. Respir Med. 2011; 106(2):243-8. DOI: 10.1016/j.rmed.2011.07.023. View

20.

Beck T . The importance of a priori sample size estimation in strength and conditioning research. J Strength Cond Res. 2013; 27(8):2323-37. DOI: 10.1519/JSC.0b013e318278eea0. View